Planning

HPV Self-sampling Cost Effectiveness Model

  • Department of Health and Social Care

F01: Prior information notice (prior information only)

Notice identifier: 2024/S 000-007803

Procurement identifier (OCID): ocds-h6vhtk-04479a

Published 12 March 2024, 10:27am



Section one: Contracting authority

one.1) Name and addresses

Department of Health and Social Care

39 Victoria Street

London

SW1H 0EU

Contact

Jay Bains

Email

jay.bains@dhsc.gov.uk

Telephone

+44 02071047545

Country

United Kingdom

Region code

UKI32 - Westminster

Internet address(es)

Main address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

Buyer's address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

one.3) Communication

Additional information can be obtained from the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

https://health-family.force.com/s/Welcome

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

HPV Self-sampling Cost Effectiveness Model

Reference number

C253383

two.1.2) Main CPV code

  • 73000000 - Research and development services and related consultancy services

two.1.3) Type of contract

Services

two.1.4) Short description

Cost-effectiveness model to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK.

two.1.5) Estimated total value

Value excluding VAT: £250,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 73210000 - Research consultancy services

two.2.3) Place of performance

NUTS codes
  • UKI32 - Westminster

two.2.4) Description of the procurement

Cost-effectiveness model to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK.
Deliverables will include the following:
• Model Specifications: Development of a model to determine the conditions under which the introduction of self-sampling in the cervical screening programme provides the most benefits in terms of clinical outcomes for women and cost-effectiveness for the programme.
• Cost effectiveness model: Running of model and analysis of cost-effectiveness.
• Model Technical Report: Interim report(s) by Spring 2025, to feed into the ISE design process.
• Model: Final report(s) in Spring 2026 clearly outlining model type, analytical approach, assumptions, uncertainties, results, and discussion, including implications to policy.
• It is expected that the final paper is published in a peer-reviewed journal to highlight the high-quality and robust work required.
• Transfer of the model’s outputs to the UK NSC

two.2.14) Additional information

1.1. For avoidance of doubt THIS IS NOT a call for competition.
This is a market consultation. The purpose is to advise suppliers of the forthcoming Department of Health and Social Care (DHSC) procurement and seek feedback from potential bidders and existing providers that may inform the final specifications and/or procurement approach to the services.

two.3) Estimated date of publication of contract notice

1 May 2024


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No